Effectiveness of mission statements in organizations – A review

2012 ◽  
Vol 18 (4) ◽  
pp. 430-444 ◽  
Author(s):  
Susanne Braun ◽  
Jenny S Wesche ◽  
Dieter Frey ◽  
Silke Weisweiler ◽  
Claudia Peus

AbstractEven though mission statements are standard tools in organizations, their effectiveness is subject to substantial skepticism. This review integrates hitherto published research based on a broad range of objective and subjective effectiveness criteria above and beyond financial performance in for-profit as well as not-for-profit organizations. We conclude that the distal outcome effectiveness of mission statements depends on the following antecedents and intermediate outcomes: (1) the rationale underlying their development; (2) the process of their development and implementation; (3) their content and form; and (4) individual attitudes toward the mission statement. We thereby clarify preconditions of mission statement effectiveness in organizations, and reveal shortcomings in current research.

2012 ◽  
Vol 18 (4) ◽  
pp. 430-444 ◽  
Author(s):  
Susanne Braun ◽  
Jenny S Wesche ◽  
Dieter Frey ◽  
Silke Weisweiler ◽  
Claudia Peus

AbstractEven though mission statements are standard tools in organizations, their effectiveness is subject to substantial skepticism. This review integrates hitherto published research based on a broad range of objective and subjective effectiveness criteria above and beyond financial performance in for-profit as well as not-for-profit organizations. We conclude that the distal outcome effectiveness of mission statements depends on the following antecedents and intermediate outcomes: (1) the rationale underlying their development; (2) the process of their development and implementation; (3) their content and form; and (4) individual attitudes toward the mission statement. We thereby clarify preconditions of mission statement effectiveness in organizations, and reveal shortcomings in current research.


2021 ◽  
Author(s):  
Tingting Qiu ◽  
Yitong Wang ◽  
Shuyao Liang ◽  
Ru Han ◽  
Mondher Toumi

Aim: Partnerships have been leveraged to advance the regenerative medicines (RMs) development. This study analyzed the evolution of partnership landscape for regenerative medicines (RMs). Methods: Partnership agreements publicly announced from January 2014 – June 2020 were described. Results: 1169 partnership agreements with total amount of US$63,496 million were identified. Most agreements concerned RMs that were for oncology (25.3%), in the discovery or preclinical phase (66.9%) and gene-based products (45.3%). The most common partnership type is collaborative agreements without licensing. The partnerships between ‘Biotechnology company and not-for-profit organizations’ represented the largest number (n = 416; 35.6%). ‘Big Pharma’ preferred collaboration and licensing agreements with a higher amount. Conclusion: Collaborations between highly specialized players with complementary expertise promote the successful translation of scientific discovery to RMs.


Sign in / Sign up

Export Citation Format

Share Document